Robinson Smith Wealth Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.04M Hold
1,127
0.7% 29
2025
Q4
$1.21M Buy
1,127
+2
+0.2% +$1.91K 0.83% 28
2025
Q3
$858K Sell
1,125
-1
-0.1% -$744 0.62% 32
2025
Q2
$878K Buy
1,126
+21
+2% +$16.3K 0.7% 28
2025
Q1
$913K Buy
1,105
+10
+0.9% +$8.32K 0.76% 28
2024
Q4
$845K Sell
1,095
-71
-6% -$58.8K 0.72% 30
2024
Q3
$1.03M Sell
1,166
-9
-0.8% -$8.09K 0.88% 26
2024
Q2
$1.06M Buy
1,175
+10
+0.9% +$8K 0.94% 26
2024
Q1
$906K Sell
1,165
-3
-0.3% -$2.13K 0.87% 28
2023
Q4
$681K Buy
+1,168
New +$682K 0.67% 40

Other funds holding LLY

Robinson Smith Wealth Advisors's LLY Position: Q1 2026 in Review

Robinson Smith Wealth Advisors held its Eli Lilly (LLY) position steady in Q1 2026 at 1,127 shares worth $1.04M. The position accounts for 0.7% of the portfolio, ranked #29.

Robinson Smith Wealth Advisors first reported a position in LLY in Q4 2023 and has held it in 10 quarters since. The position peaked at $1.21M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Robinson Smith Wealth Advisors held 1,127 shares of Eli Lilly worth $1.04M as of Q1 2026.
  • Robinson Smith Wealth Advisors left its Eli Lilly share count unchanged in Q1 2026.
  • Eli Lilly made up 0.7% of Robinson Smith Wealth Advisors's portfolio in Q1 2026, its #29 holding.
  • Robinson Smith Wealth Advisors first reported a position in Eli Lilly in Q4 2023 and has held it in 10 quarters since.
  • Robinson Smith Wealth Advisors's Eli Lilly position peaked at $1.21M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Robinson Smith Wealth Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.